logo
UP to promote use of Panchgavya-based products in all dists

UP to promote use of Panchgavya-based products in all dists

Time of India02-07-2025
Lucknow: Aiming to encourage natural farming and increase organic agricultural productivity, the state govt is planning to use growth promoters and organic pesticides in all 75 districts of the state.
Tired of too many ads? go ad free now
According to a state govt spokesperson, the campaign will impact all three fronts of employment, environmental protection, and agricultural reform.
According to experts, this will ensure the safety of crops and increase productivity by 20%. The spokesperson said that a comprehensive plan was prepared for the production and marketing of 'Panchgavya' products made from cow dung, cow urine, milk, curd, and ghee.
By joining this scheme, women in rural areas will become self-reliant, and local youth will get new employment opportunities at the local level. Under the scheme, women of self-help groups in each district will be given the responsibility of manufacturing, marketing, and training of Panchgavya-based products.
In addition, farmers will be given special training programs so that farming can be made chemical-free and environmentally friendly.
Anurag Srivastava, OSD of Uttar Pradesh Gau Seva Commission, said that recently the commission conducted a state-wide inspection and studied livestock density, available land, water sources, and cow shelters. Besides this, an action plan was made to connect local youth in the marketing of growth promoters and organic manure.
"This will give new impetus to organic farming. On the other hand, local employment opportunities will be generated in the rural economy," the spokesperson said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lodha Developers eyes ₹1,500 crore rental income in FY31, says MD
Lodha Developers eyes ₹1,500 crore rental income in FY31, says MD

Business Standard

time31 minutes ago

  • Business Standard

Lodha Developers eyes ₹1,500 crore rental income in FY31, says MD

Lodha Developers is targeting a six-fold jump in the annual rental income by 2030-31 to ₹1,500 crore, which will cover almost the entire interest and salary cost of the company, its MD Abhishek Lodha said. After capturing a decent market share in the housing segment, Mumbai-based Lodha Developers intends to scale up its commercial real estate business. It is building office complexes, retail projects and industrial and warehousing parks, besides entering into facilities management. The company's annuity income, which includes rents from leased commercial assets, stood at ₹250 crore in the last fiscal year. In a letter to shareholders, Lodha Developers MD and CEO Abhishek Lodha said the company now aims to have a reasonable annuity income portfolio over time. He said the "aim is to have ₹15 billion (Rs 1,500 crore) annuity income by 2030 (FY31)". Abhishek noted that the targeted annuity income for 2030-31 would be enough to cover almost the entire interest and salary costs of the company. During the 2024-25 fiscal year, the company acquired land in Chennai and Delhi-NCR for warehousing parks. "Leasing at various parks is progressing well, and we are continually enhancing our high street retail portfolio alongside our residential projects. We look to meaningfully grow in annuity income in the next few years," Abhishek said. At present, Lodha Developers has a commercial portfolio of 8.4 million square feet, of which 2.1 million square feet is retail, 1 million square feet of office space and 5.3 million sq ft of industrial and warehousing parks, according to an investor's presentation. Out of this 8.4 million square feet area, 3 million square feet were leased till March this year. From the current portfolio, the company expects a total annuity income of Rs 1,150 crore in FY31. About Rs 550 crore will be from office and retail space, while nearly Rs 300 crore will come from warehousing parks and Rs 300 crore from facilities management. It will increase the size of its commercial portfolio in the coming years to reach the targeted annuity income of Rs 1,500 crore in FY31. In the letter to shareholders, Abhishek outlined the vision of the company for the short, medium and long term. He also talked about the importance of having predictable growth with consistency to reduce business risk. In housing, Abhishek said the company is strategically positioned to continue to grow pre-sales at about 20 per cent CAGR (compounded annual growth rate) over a long period. In 2024-25, the company's pre-sales or sales bookings stood at a record Rs 17,630 crore, up 21 per cent annually. Addressing shareholders in the annual report for the last fiscal, he said the company is focusing on mid-income, premium and luxury homes across the Mumbai Metropolitan Region (MMR), Pune and Bengaluru markets. Going ahead, Abhishek said, the company would focus on scaling its presence in these three markets and would enter a new city in the pilot phase. He said the company remains committed to keeping its leverage at a very conservative level, where net debt to equity will be below 0.5 times. "As we expand, we remain resolute in integrating sustainability at the core of our developments, ensuring they are future-ready and resilient," said Abhishek. Lodha Developers has built more than 100 million square feet and is developing more than 110 million square feet under its ongoing and planned portfolio. Its net profit increased to Rs 2,764.3 crore in 2024-25 from Rs 1,549.1 crore in the preceding year. The total income grew to Rs 14,169.8 crore last fiscal from Rs 10,469.5 crore in the 2023-24.

IIT-IIM degrees, Goldman Sachs job. Left everything to know more about security guards. Who is Abhishek Kumar, co-founder of MyGate?
IIT-IIM degrees, Goldman Sachs job. Left everything to know more about security guards. Who is Abhishek Kumar, co-founder of MyGate?

Time of India

timean hour ago

  • Time of India

IIT-IIM degrees, Goldman Sachs job. Left everything to know more about security guards. Who is Abhishek Kumar, co-founder of MyGate?

His education and career Spark behind the pivot? About MyGate About Abhishek Kumar A mission rooted in real experience At a time when most would chase promotions and perks in glass towers, Abhishek Kumar did the unthinkable. An IIT Kanpur graduate with an MBA from IIM Ahmedabad , and then a Vice President at Goldman Sachs , he quit his high-profile job to shadow security guards in gated societies. Not for a documentary, not as a social experiment—but to build something that would redefine urban community living in India . That idea became MyGate Abhishek's journey began at Delhi Public School, R.K. Puram, one of India's most prestigious schools. He then went on to pursue a from the Indian Institute of Technology, Kanpur, followed by an MBA from the Indian Institute of Management, Ahmedabad. Armed with a world-class education, he entered the finance world and spent six years at Goldman Sachs, eventually rising to the position of Vice President. But the boardroom didn't satiate his long-term drastic shift wasn't impulsive—it was sparked by a vision shared by Vijay Arisetty , a Shaurya Chakra awardee , former Indian Air Force pilot, and alumnus of NDA and ISB. In 2016, Arisetty foresaw the rise of smart community living and the pressing need for secure, connected, and digitized residential societies. Alongside him were Abhishek Kumar and Shreyans Daga, an IIT Guwahati and ISB one of his LinkedIn posts , he wrote that 9 years back, he was shadowing the security guards for several weeks to gain more insights for their app. He decided to step into the shoes again and did a full 12 hours shift of a guard from 8 am to 8 pm for a trio—each from a vastly different background—came together to co-found Bengaluru-based app, MyGate, a community management app that today handles over 720,000 requests every minute and has processed more than 6 billion entries across India. Its mission? To enhance daily living with security, convenience, and some startup founders skim user data for insights, Abhishek went boots-on-the-ground. He spent months observing and speaking with security guards, understanding the operational gaps. What began as a digital gatekeeping solution quickly expanded into an ecosystem, helping residents discover local services, purchase property, and even file society tickets, of which over 6 million have been resolved through the to Tracxn, Vijay Arisetty, together with Daga and Kumar, the trio built MyGate into a Rs 1,670 crore powerhouse, transforming how Indians experience community living.

Cipla to enter weight management segment in India: MD & Global CEO Vohra
Cipla to enter weight management segment in India: MD & Global CEO Vohra

Business Standard

timean hour ago

  • Business Standard

Cipla to enter weight management segment in India: MD & Global CEO Vohra

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said. The Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25. "Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra stated. Several domestic drug firms are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes management. US drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in the country. Danish firm Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular events. In the CNS segment, Cipla has successfully in-licensed Sanofi's India CNS product range, including Frisium, a leading brand in the anti-epileptic category, Vohra informed shareholders. "Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease," he said. The company is equally committed to addressing the global crisis of antimicrobial resistance (AMR), he added. "Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," Vohra said. He noted that the company's ambition is to be a global, innovation-led, patient-centric healthcare company that creates long-term value through science, empathy, and sustainability. "We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," Vohra stated. Cipla's consolidated revenue stood at Rs 27,548 crore in FY25. Its consolidated net profit rose to Rs 5,272 crore during the period.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store